Oct 30, 2013 by Amy HoWebMD Rides Road to RecoveryLatest stock repurchase by WebMD occurs as it begins to surpass consensus estimates.
Oct 29, 2013 by Amy HoBristol-Myers Squibb Advances in Rheumatoid Arthritis and CancerStacked announcements of positive study results help mitigate Bristol-Myers Squibb's patent expirations.
Oct 23, 2013 by Amy HoThe Race Is On for the Next Big Hepatitis C TherapyJohnson & Johnson and Gilead expect FDA approvals of new hepatitis C treatments this week.
Oct 23, 2013 by Amy HoDiabetes Giants Battle Outside of Their Usual ArenaNovo Nordisk makes headway in diabetes and bleeding disorders as Sanofi and Merck continue to grapple over cholesterol.
Oct 7, 2013 by Amy HoSmoke and Mirrors: European Parliament May Clear the Air on E-CigarettesPending legislation on e-cigarettes in Europe will shape big tobacco in the United States.
Oct 1, 2013 by Amy HoRoche Pulls Ahead in Immunotherapy RaceProgrammed cell death breathes life into a potential $35 billion drug industry.
Sep 24, 2013 by Amy HoLittle Changed for Sarepta After Prosensa ImplosionA look at the market for Duchenne muscular dystrophy drugs after a big trial failure.
